Greenleaf Trust Bausch Health Companies Inc. Transaction History

Greenleaf Trust

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $129,388 - $433,067	-18,327 Reduced 45.11%	22,298 $186,000
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $1,150 - $1,450	50 Added 0.12%	40,625 $1.12 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $469,550 - $563,685	-18,752 Reduced 31.61%	40,575 $1.13 Million
Q2 2021 Aug 10, 2021	BUY	$27.43 - $32.7 $1.23 Million - $1.47 Million	45,000 Added 314.09%	59,327 $1.74 Million
Q3 2020 Oct 30, 2020	SELL	$14.88 - $20.13 $12,261 - $16,587	-824 Reduced 5.44%	14,327 $223,000

Q2 2020 Aug 12, 2020	BUY	$13.31 - $20.51 $39,011 - $60,114	2,931 Added 23.99%	15,151 $277,000
Q1 2020 Apr 29, 2020	SELL	$12.98 - $30.25 $48,869 - $113,891	-3,765 Reduced 23.55%	12,220 $189,000
Q1 2019 May 08, 2019	SELL	$20.23 - $26.29 $25,267 - $32,836	-1,249 Reduced 7.25%	15,985 $395,000
Q4 2018 Feb 07, 2019	BUY	$17.64 - $28.32 $511 - $821	29 Added 0.17%	17,234 $318,000
Q3 2018 Oct 29, 2018	BUY	$20.64 - $25.67 $355,111 - $441,652	17,205 New	17,205 $442,000

261

204M

2.54M

6.46M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

Stay updated on Greenleaf Trust with notifications on news.